No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Morgan Stanley Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $230
Inspire Medical Systems To Present At J.P. Morgan Healthcare Conference; Webcast At 11:15 AM ET
Positive Growth Prospects Reinforce Buy Rating for Inspire Medical Systems
Lake Street Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $270
Inspire Medical Systems Sees Higher Q4 Revenue; Sets Fiscal 2025 Revenue Outlook
Investing in Inspire Medical Systems (NYSE:INSP) Five Years Ago Would Have Delivered You a 146% Gain